Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal
about
Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.Hazardous compounds in tobacco smokeLung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a reviewDifferent profiles of carcinogen exposure in Chinese compared with US cigarette smokersUrinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approachAn inter-laboratory comparison of urinary 3-hydroxypropylmercapturic acid measurement demonstrates good reproducibility between laboratoriesAbuse liability assessment of tobacco products including potential reduced exposure productsNew insights into the formation of volatile compounds in mainstream cigarette smoke.Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco.Cigarettes sold in China: design, emissions and metals.Cigarette characteristic and emission variations across high-, middle- and low-income countries.Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption.Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes.Transgenic and mutation-based suppression of a berberine bridge enzyme-like (BBL) gene family reduces alkaloid content in field-grown tobacco.Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control ActTobacco and nicotine product testing.Comparative Risks of Aldehyde Constituents in Cigarette Smoke Using Transient Computational Fluid Dynamics/Physiologically Based Pharmacokinetic Models of the Rat and Human Respiratory Tracts.Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studiesBenzene Uptake and Glutathione S-transferase T1 Status as Determinants of S-Phenylmercapturic Acid in Cigarette Smokers in the Multiethnic Cohort.Toxic metal concentrations in mainstream smoke from cigarettes available in the USA.Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.Acrolein Exposure in U.S. Tobacco Smokers and Non-Tobacco Users: NHANES 2005-2006.The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the USMonitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products.Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction.Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smokeA comprehensive evaluation of selected components and processes used in the manufacture of cigarettes: approach and overview.Brand variation in oxidant production in mainstream cigarette smoke: Carbonyls and free radicals.E-cigarette vapour is not inert and exposure can lead to cell damage.Integrating the impact of cigarette and waterpipe tobacco use among adolescents in the Eastern Mediterranean Region: a cross-sectional, population-level model of toxicant exposure.Swedish snus and the GothiaTek® standard.Electron Microscopic Analysis of Silicate and Calcium Particles in Cigarette Smoke Tar.Acrolein exposure in hookah smokers and non-smokers exposed to hookah tobacco Secondhand Smoke: Implications for regulating hookah tobacco products.Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.
P2860
Q27347505-78A7EB54-C102-4E14-A8AD-649F1760B3ADQ27692101-8ECF468E-8DFD-4D1F-99EA-11B76DDA4205Q28237162-96D4A0AD-8E62-4223-BC63-952F25F62018Q28389865-751F9AFE-8CCB-4FAA-8DC6-80B52F29339FQ28396981-75120A73-9047-4336-8A05-F1D898E231A2Q28662000-216E0DB5-5EDB-4856-8A87-056248710B32Q28743148-F2FAA985-9E1B-4C8E-944D-291ADFF12C4BQ33559301-3A922E34-D873-46D0-B0DC-D99B1DE92ED0Q33674193-F54A808F-12CF-4177-A904-44F19B6A75DDQ33936367-BC98824E-1633-4C9D-83C9-EA91E94C90CFQ34056291-DB3376C5-EAE7-492A-A945-7D2B8A91A720Q34289442-2AC81E8B-E43B-4ADD-8CD1-30C42BE10E7BQ34388209-A2528020-0E18-4D42-BBAE-F534F695ABE9Q34517983-277EAC8B-B692-4845-A994-048A175FFCE0Q34550683-EAFB6476-3BB4-44C4-BB40-72EE67CB0DC4Q34877983-6CA676CB-1D7D-404C-8200-9AC38C2D3E28Q35562592-F5D8A259-9D88-44CA-8CFE-90B550882374Q35624461-5CF9E1D5-9DAD-49D6-B552-C2C631B5630DQ35624469-8E661692-0B3D-4F68-A25A-257EDD88181AQ35766443-59ED0FCF-559E-43EE-B3D5-FCF93CEC76A1Q35811682-5CDE1E14-5D20-415B-95AB-FB17394D5C39Q35951033-34202BC9-8E85-4C94-B003-28546C175075Q35965661-42911F7F-DF5D-4D92-94BE-C5195D82919EQ36047534-309787EA-2E1F-4071-AD82-00F7B62BA713Q36350853-DE0F66C3-2D76-45C6-B647-03308380A656Q37024750-690501BD-9734-4B27-A1A3-C895C305D301Q37155822-0936C192-FB12-4E9C-B7DD-603D597F55FFQ37380761-09CCCD57-4899-407D-A043-78780289B864Q37461637-77A4EE79-B13C-4C66-8AAC-A0B349D0434AQ37461696-288300C7-A6EC-4E39-A0D0-7DEFED024528Q37486147-2F3D4A60-4C01-46D2-A270-A7B415471CD1Q37642791-B45AFB22-A302-4B30-8405-B2DCA07C1496Q38171569-856C08AE-2527-41F2-89D7-D22D029915CBQ38772399-BE97A5A7-F1A5-4492-A95B-B84988A53A0EQ38783313-2D769739-329C-4ABC-AB43-33B617C85932Q39646877-E42ABE13-BA2F-4073-8CEB-337A1F816104Q39749844-4FE91459-265C-467C-ABBB-9696497F6BD5Q39783757-5F179C5B-8557-4671-A1FB-C8C8A15997CEQ40168769-DF3D009E-6624-4DE7-82DB-D94468AC5567Q40348713-141B7403-F2A5-42F9-A544-20ACEAB93D5A
P2860
Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mandated lowering of toxicants ...... h Organization TobReg proposal
@en
type
label
Mandated lowering of toxicants ...... h Organization TobReg proposal
@en
prefLabel
Mandated lowering of toxicants ...... h Organization TobReg proposal
@en
P2093
P2860
P356
P1433
P1476
Mandated lowering of toxicants ...... h Organization TobReg proposal
@en
P2093
A Opperhuizen
C Anderson
M Djordjevic
P2860
P304
P356
10.1136/TC.2007.024158
P577
2008-04-01T00:00:00Z